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Abstract 
Beetroot juice (BRJ) has been shown to increase NO-dependent dilation through both 
NOS-dependent and NOS-independent pathways. We hypothesized BRJ supplementation would 
augment reflex cutaneous active vasodilation. Subjects were equipped with two microdialysis 
fibers on the forearm and randomly assigned as control (Ringer’s) or NOS inhibition (20mM L-
NAME). Whole-body heating was achieved via water-perfused suits to raise core temperature 
(Tc; ingestible telemetric pill) 0.8°C. Maximal cutaneous vasodilation was reached by 
administering 54mM SNP and local heating to 43°C. Skin blood flow was measured via laser-
Doppler flowmetry and mean arterial pressure determined; cutaneous vascular conductance 
(CVC) was calculated and expressed as %CVCmax.  Subjects underwent heat stress pre- and post-
nitrate supplementation (3 days of BRJ: 5mM, 0.45g nitrates per day). BRJ increased the plateau 
CVC at control (pre: 57 ± 3 vs. post: 80 ± 5 %CVCmax) and L-NAME (pre: 36 ± 3 vs. post: 52 ± 
6 %CVCmax; p<0.05 for all conditions) sites.  The %NO contribution increased from pre- to post-
BRJ (pre: 44 ± 5 %CVCmax vs. post: 64 ± 6 %CVCmax; p<0.05). These data suggest that BRJ 
augments the NOS-dependent and NOS-independent component of reflex cutaneous 
vasodilation. 
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Chapter 1 - Introduction 
In humans, the onset of heat stress initiates a rise in core temperature and is associated 
with an increase in cutaneous vasodilation and sweating (Fox et al. 1958). It is well known that 
the cutaneous circulation is regulated by two branches of the sympathetic nervous system 
(Kellogg et al. 1995; Kellogg et al. 1998; Rowell et al. 1974). These include the adrenergic 
vasoconstrictor nerves and the cholinergic active vasodilator nerves (Kellogg et al. 2006). With 
an increase in core body temperature, the sympathetic cholinergic vasodilator nerves reflexively 
mediate increases in skin blood flow and can direct 60% of cardiac output, or ~8 l/min of blood 
flow to the skin (Edholm et al. 1957; Kellogg et al. 1995; Kellogg et al. 2006; Rowell et al. 
1974).  
The mechanisms for control of the cutaneous active vasodilator system in human skin 
remain unresolved. The current, accepted mechanism to explain cutaneous active vasodilation in 
response to body heating is the co-transmission theory (Kellogg et al. 1995). This theory 
suggests the release of acetylcholine and an unknown substance(s) are responsible for the sweat 
response and cutaneous vasodilation, respectively. Kellogg et al. provided evidence for 
acetylcholine as the primary mechanism for the sweat response to passive heat stress, inasmuch 
as a muscarinic receptor antagonist eliminated the sweat response, which resulted in minimal 
attenuation of the cutaneous vasodilator response (Kellogg et al. 1995). However, it remains to 
be elucidated as to if any one vasodilator is involved, or rather if it is a combination of several 
potential vasodilators that contribute to the responses observed in reflex vasodilation. A 
multitude of potential vasodilators and vasodilator pathways have been proposed as possible 
substances to support the co-transmission theory. These vasodilators include: neurokin-1 
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receptors (Wong et al. 2005), vasoactive intestinal peptide (VIP) (Bennett et al. 2003), VIP 
receptors (VPAC; Kellogg et al. 2010), histamine 1 (H1) receptors (Wong et al. 2004), transient 
receptor potential vanilloid type-1 (TRPV-1) channels (Wong & Fieger, 2012), prostaglandins 
(McCord et al. 2006), and nitric oxide (NO) (Kellogg et al. 1998; Wilkins et al. 2003). In 
addition to these co-transmitters for active vasodilation, Figure 1 demonstrates other potential 
mechanisms also contribute to the skin blood flow response in healthy humans during reflex 
cutaneous vasodilation. Pathways and production of nitric oxide in heat stress conditions will be 
further examined in the present investigation. 
 
 
 
 
 
 
 
 
 
 
Figure 1. Potential mechanisms for control of skin blood flow during reflex 
cutaneous vasodilation. This figure demonstrates a collection of factors influencing 
cutaneous blood flow with specific attention to NO through the NO-dependent 
pathway (i.e., L-arginine) and the NO-independent pathway (i.e., nitrate reduction to 
nitrite, and subsequently to NO). 
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Nitric oxide has been shown to contribute ~35-45% to cutaneous active vasodilation 
(Kellogg et al. 1998; Shastry et al. 1998). The NO component to cutaneous active vasodilation 
was demonstrated through blockade of nitric oxide synthase (NOS), resulting in an attenuated, 
but not abolished skin blood flow response to whole body heating (Kellogg et al. 1998), 
suggesting full expression of NO was required to achieve reflex cutaneous vasodilation. 
However, the precise mechanism underlying the release of NO during passive heat stress was 
unknown (Shastry et al. 1998). Wilkins et al. (2003) subsequently demonstrated that NO has a 
direct vasodilator role to reflex cutaneous vasodilation and may also work synergistically with 
the unknown transmitter(s) (Wilkins et al. 2003). Recent evidence from Kellogg et al. (2008) 
determined the specific NOS isoform responsible for active vasodilation to be neuronal nitric 
oxide synthase (nNOS), activated by centrally mediated reflex responses to passive heat stress. 
The classical pathway used for NO generation through the conversion of L-arginine (with 
cofactors Ca2+ and BH4) to L-citrulline and NO has been shown to be NOS-dependent, and thus 
requires oxygen for the conversion to NO (Moncada et al. 1993). Conversely, the nitrate-nitrite-
NO pathway has been shown to be a NOS-independent pathway for NO generation, when the 
NOS-dependent pathways and its corresponding enzymes are compromised, such as in hypoxic 
conditions (i.e. low PO2) or a state of acidosis (Benjamin et al. 1994, Lundberg et al. 1994, 
Lundberg et al. 2008). Nitrate and nitrite derive from two primary sources: endogenously via the 
L-arginine classical pathway for NO production or through exogenous sources in the diet such as 
vegetable consumption (i.e. leafy greens such as spinach and beetroot) (Lundberg et al. 2004; 
Lundberg et al. 2008). The conversion from nitrate to nitrite, and subsequently to NO requires 
the enterosalivary circulation and the upper gastrointestinal tract (Govoni et al. 2004; Lundberg 
et al. 2004). Nitrate is rapidly reduced to nitrite by anaerobic facultative commensal bacteria and 
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other reductase enzymes in the mouth and saliva (Govoni et al 2008; Lundberg et al. 2004). 
Nitrate can further be reduced to nitrite in the acidic state of the stomach and small intestine, 
where nitrite can be actively taken up by the salivary circulation, enter the systemic circulation, 
or subsequently be converted to NO (Lundberg et al. 2004). 
Recent literature provides evidence of cardiovascular health benefits elicited from 
consumption of nitrate sources in both healthy and disease populations. Consumption of dietary 
nitrates has been shown to increase exercising skeletal muscle blood flow (Ferguson et al. 2012), 
reduce the oxygen cost of exercise (Bailey et al. 2009; Larsen et al. 2007), improve exercise 
tolerance in peripheral artery disease patients (Kenjale et al. 2011), and to lower blood pressure 
(Webb et al. 2008; Larsen et al. 2006). It has been suggested that many of these cardiovascular 
benefits are due to an increase in bioavailable NO originating from the reduction of nitrate to 
nitrite and subsequently to NO.  
There are multiple factors and mechanisms responsible for control of skin blood flow in 
reflex cutaneous vasodilation in healthy humans. As demonstrated in Figure 1, there are 
additional neural and humoral stimuli, including the previously stated co-transmitters and 
potential vasodilator(s) that regulate cutaneous blood flow. NO is required for full expression of 
reflex cutaneous vasodilation, thus the focus of the present investigation was to identify a role for 
NO production through both the NOS-dependent and NOS-independent pathways via dietary 
nitrates under passive heat stress conditions.  
Reflex cutaneous vasodilation has been shown to be attenuated in healthy aged 
individuals as well as in disease populations, such as hypertension and hypercholesterolemia 
(Holowatz et al. 2003; Holowatz et al. 2007). The reduced thermoregulatory response in these 
individuals has been attributed, in part, to a decrease in bioavailable NO. Inasmuch as dietary 
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nitrates have previously been shown to yield various cardiovascular health benefits and increase 
bioavailable NO, it is possible that dietary nitrate supplementation may improve cutaneous blood 
flow and thermoregulation in healthy populations. The effect of dietary nitrate supplementation 
on cutaneous blood flow in response to passive heat stress is currently unknown. Therefore, the 
purpose of the present investigation was to determine the effects of dietary nitrate 
supplementation via beetroot juice on the skin blood flow response to whole body heating. We 
hypothesized that three days of nitrate supplementation via beetroot juice would augment the NO 
component of cutaneous reflex vasodilation in healthy humans. 
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Chapter 2 - Methods 
 Subjects and Ethical Approval 
Seven subjects (7 men; age 22 ± 1 yr; height 179 ± 8 cm; body mass 80 ± 14 kg; body 
mass index 25 ± 4 kg/m2) volunteered to participate in this study. The Institutional Review Board 
at Kansas State University approved all protocols of the study, and written and verbal informed 
consent was obtained from each subject prior to participation. All studies conformed to 
guidelines as set forth by the Declaration of Helsinki. All subjects participated in a standard 
health history screening to verify the absence of cardiovascular disease, non-obese, and 
nonsmoking status. All tests were performed with the subjects in the supine position and the 
experimental arm at heart level.  
 Dietary Nitrate Supplementation and Intervention 
All subjects reported to the laboratory for pre-and post-supplement experimental sessions 
(see below). Following the pre-supplement experimental session, all subjects were instructed to 
consume 70 ml/day of 0.45 g concentrated nitrate-enriched beetroot juice shot (Beet It, James 
White Drinks, Ipswich, UK) as one 70 ml shot per day for three days (Bailey et al. 2009; Larsen 
et al. 2007). The third 70 ml shot was consumed in the laboratory approximately two hours prior 
to the start of the post-supplement whole body heating protocol. Consumption of nitrates 
approximately 1.5-2 hours prior to the start of the protocol has previously been demonstrated to 
elicit peak circulating plasma nitrite levels (Webb et al. 2008; Vanhatalo et al. 2010). All 
subjects were asked to refrain from exercise, caffeine, and alcohol 12 hours prior to pre-testing 
and during the three days of beetroot juice supplementation. The subjects were also asked to 
refrain from eating foods high in nitrate content, such as leafy greens (e.g., spinach, > 300 
g/day), and to refrain from using antibacterial mouthwash products before testing and during the 
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supplementation period (Govoni et al. 2008). A venous blood sample was taken prior to each 
experimental protocol to determine plasma nitrate and nitrite concentration for both pre- and 
post-supplement whole body heating trials. Blood samples were centrifuged and stored in a 
nitrite-free EDTA vacutainer and stored at -80°C. Subjects were instructed to fast for 9-12 hours 
prior to blood sampling.  
 Instrumentation 
During both pre- and post-supplement testing, the subjects were equipped with two 
microdialysis fibers on the ventral side of the left forearm. Ice was used to numb the skin before 
fiber placement (Hodges et al. 2009). Microdialysis fibers were placed by using a 23-gauge 
needle inserted into the intradermal layer of the skin. The fibers were then threaded through the 
lumen of the needle; the needle was removed from the skin leaving the semi-permeable 
membrane of the fiber in place under the skin. Microdialysis fibers were used to perfuse drugs to 
local areas of the skin on the forearm. The membranes of the microdialysis fibers were 10 mm in 
length with a 55-kDa molecular mass cutoff (CMA 31 Linear Probe; CMA Microdialysis; Kista, 
Sweden). Placement of the microdialysis fibers results in a mild trauma response that was 
allowed to subside (~45-90 minutes) before starting the whole body heating protocol.  
Laser Doppler flowmetry was used as an index of skin blood flow by measuring red 
blood cell flux. Local heating units were placed directly over the center of each microdialysis site 
(PF5020 local heating units and PeriFlux 5020 Temperature Unit; Perimed; Jarfalla, Sweden). 
An integrated laser-Doppler probe (Probe 413; Perimed; Jarfalla, Sweden) with seven emitting 
and receiving probes were placed in the center of each local heating unit, to measure red blood 
cell flux directly over each microdialysis site. 
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Subjects wore a water-perfused suit to control whole body temperature (Allen Vanguard, 
Ottawa, Ontario, Canada) that covered the entire body except for the hands, feet, head, face, and 
the experimental forearm. The water-perfused suit was covered with a water impermeable rain 
suit to limit evaporative heat loss during whole body heating.  
 Subject Monitoring 
Core body temperature was measured via telemetric ingestible pill (CorTemp Data 
Recorder, CorTemp Temperature Sensor, Wireless Sensing Systems and Design, Palmetto, FL, 
USA). Subjects were instructed to ingest the pill approximately 2-3 hours prior to arriving at the 
laboratory the day of each experimental test. Temperatures were recorded approximately every 
minute during baseline, the period of whole body heating, and during the cooling period. Whole 
body heating persisted until subjects’ core temperature was raised 0.8-1.0°C.  
Subjects’ heart rates were monitored with an electrocardiogram throughout the duration 
of the protocol. Blood pressure was measured beat-by-beat via photoplethysmography 
(NexfinHD; BMEYE, Amsterdam, The Netherlands) with a cuff placed on a finger on the right, 
non-experimental arm. Beat-by-beat blood pressure was verified via automated brachial 
auscultation on the right, non-experimental arm every 5 minutes (S/5 Light Monitor; Datex-
Ohmeda, GE Healthcare; Madison, WI, USA).  
 Protocols 
Baseline skin blood flow, blood pressure, and core temperature data were collected for 
10-15 minutes following the trauma response following microdialysis placement. During this 
time thermoneutral water (32-33°C) was pumped through the water-perfused suit. Drug infusion 
through each microdialysis site was randomized and each site received one of two treatments: 1) 
lactated Ringer’s solution that served as a control; 2) 20 mM of the L-arginine analog NG-nitro-
9 
 
L-arginine methyl ester (L-NAME; Tocris Bioscience; Minneapolis, MN, USA) dissolved in 
lactated Ringer’s solution to inhibit nitric oxide synthase (Kellogg et al. 1999). See Figure 2 for a 
representative schematic of drug infusions in the whole body heating protocol. All drugs were 
perfused for approximately 60 minutes prior to starting whole body heat stress. Drugs were 
perfused via microdialysis at a rate of 2µl/min with a microinfusion pump (Bee Hive controller 
and Baby Bee Syringe Pumps, Bioanalytical Systems, West Lafayette, IN).  
 
 
 
 
 
 
 
 
 
 
 
Whole body heat stress was initiated by pumping 50°C water through the water-perfused 
suit. Whole body heating continued until subjects’ core temperature was raised 0.8-1.0°C above 
baseline. Core temperature was maintained at this level until a 5-10 minute plateau in skin blood 
flow for both sites was reached. Once a plateau in skin blood flow was achieved, 20 mM L-
NAME was infused into the control site until skin blood flow decreased and reached a plateau. 
Once a new plateau was achieved at the control site in response to L-NAME (post-L-NAME 
drop), subjects were cooled by pumping thermoneutral water through the suit and the plastic rain 
54	  mM	  SNP	  +	  Local	  
Heating	  to	  43°C	  
20	  mM	  L-­‐NAME	  
Ringers’	  (Control)	  	   20	  mM	  L-­‐NAME	  
Whole	  Body	  Heating	  	  
Heat	  stress	  to	  raise	  core	  temp	  0.8°C	  above	  baseline	  
Baseline	  
1	  
2	  
Figure 2. Schematic illustration of the experimental protocol.  Following microdialysis 
placement and trauma resolution, Ringer’s and L-NAME were infused prior to and during 
whole body heating. L-NAME was infused into the control site once core temperature was 
raised 0.8°C above baseline. Whole body heating via 50°C was used to raise core temperature 
0.8°C above baseline. At the end of the whole body heat stress protocol, all sites were 
simultaneously infused with 54 mM SNP and locally heated to 43℃ to elicit maximal 
vasodilation.   
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suit was removed. Maximal skin blood flow was elicited via infusion of 54mM sodium 
nitroprusside (SNP) at a rate of 4µl/min and by increasing the temperature of the local heaters to 
43°C. This dose of SNP with local heating has been previously shown to elicit maximal 
cutaneous vasodilation in human skin (Kellogg et al. 1999).  
 Data Acquisition and Analysis  
Data were digitized and stored at 50 Hz on a personal computer and analyzed offline 
using signal-processing software (Windaq; Dataq Instruments, Akron, OH, USA). Skin blood 
flow data was converted to cutaneous vascular conductance (CVC), calculated as red blood cell 
flux divided by mean arterial pressure (RBF/MAP). CVC data was expressed as a percentage of 
maximal vasodilation (%CVCmax) via SNP infusion and local heating to 43°C. CVC data were 
averaged over a stable 5 minute period for baseline, whole body heating plateau, and maximal 
skin blood flow.   
Percent nitric oxide synthase component (%NOS) dependent vasodilation was calculated 
using the following equation: %NOS = [( Control WBH plateau before L-NAME –  Control 
post-L-NAME drop) /  Control WBH plateau before L-NAME] * 100 
Data was analyzed using one-way and two-way repeated-measures ANOVA and paired t-
tests as appropriate. All statistical analyses were performed using SigmaStat 3.5 (Systat 
Software; Point Richmond, CA, USA). All values are presented as mean ± SEM and p-values < 
0.05 were considered statistically significant.  
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Chapter 3 - Results 
 Pre- and post-BRJ systolic, diastolic, and mean arterial blood pressure data are shown in 
Figures 3-5, respectively, at baseline, during whole body heating, and at the end of the protocol 
(i.e., during SNP infusion and local heating to 43°C; thermoneutral conditions). Systolic blood 
pressure was not significantly different from pre-BRJ to post-BRJ for any phase of the protocol, 
as depicted in Figure 3.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Values are mean ± SEM. There was no significant difference in systolic blood pressure 
pre- to post-BRJ in any phase of the whole body heating protocol. Plateau defined as the plateau 
during whole body heating at a 0.8°C increase in core temperature. 
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Diastolic blood pressure (Figure 4) was significantly reduced at baseline from pre-BRJ to 
post-BRJ (79 ± 3 mmHg vs. 66 ± 3 mmHg; p < 0.05) and at the end of the protocol (pre: 74 ± 2 
mmHg vs. post: 63 ± 3 mmHg; p < 0.05). There was no effect of BRJ on diastolic blood pressure 
during whole body heating (pre: 68 ± 2 mmHg vs. post: 66 ± 2 mmHg).  
Figure 4. Values are mean ± SEM. Diastolic blood pressure was significantly reduced pre- to 
post-BRJ. Diastolic blood pressure at baseline and at the end of the protocol was significantly 
reduced pre vs. post-BRJ. Diastolic blood pressure during the plateau of whole body heating 
was significantly reduced compared to baseline and the end of the protocol for pre-BRJ only. 
Plateau defined as the plateau during whole body heating at a 0.8°C increase in core 
temperature. End of protocol defined as return to thermoneutral conditions during SNP 
infusion and local heating to 43°C. 
*, p < 0.05 vs. pre-BRJ 
#, p < 0.05 vs. baseline, end of protocol 
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Figure 5 displays mean arterial pressure data for each phase of the protocol. Mean arterial 
pressure at baseline was significantly reduced from pre-BRJ (97 ± 4 mmHg) to post-BRJ (82 ± 4 
mmHg; p < 0.05) and mean arterial pressure at the end of the protocol was significantly reduced 
from pre-BRJ (93 ± 1 mmHg) to post-BRJ (79 ± 4 mmHg; p < 0.05). There was no effect of BRJ 
supplementation on mean arterial pressure during whole body heating (pre: 85 ± 3 mmHg vs. 
post: 80 ± 1 mmHg). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Values are mean ± SEM. Mean arterial pressure was significantly attenuated 
pre- to post-BRJ for three days. Mean arterial pressure at baseline and at the end of the 
protocol was significantly reduced pre- to post-BRJ. Mean arterial pressure during the 
plateau of whole body heating was significantly reduced compared to baseline and the 
end of the protocol for pre-BRJ only. Plateau defined as the plateau during whole body 
heating at a 0.8°C increase in core temperature. End of protocol defined as return to 
thermoneutral conditions during SNP infusion and local heating to 43°C. 
*, p < 0.05 vs. pre-BRJ 
#, p < 0.05 vs. baseline, end of protocol 
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Figure 6 shows the group mean whole-body heating plateau %CVCmax data. The increase 
in %CVCmax at the plateau during whole body heating was augmented pre- to post-BRJ for both 
the control (pre-BRJ: 57 ± 3 %CVCmax vs. post-BRJ: 80 ± 5 %CVCmax; p < 0.05) and L-NAME 
treatment site (pre-BRJ: 36 ± 3 %CVCmax vs. 52 ± 6 %CVCmax; p < 0.05). The increase in CVC 
at L-NAME sites was attenuated compared to control sites both pre- and post-BRJ (p < 0.05 for 
all conditions). 
Figure 6. Values are mean ± SEM. There was a significant increase in the whole body heating 
plateau %CVCmax from pre- to post-BRJ for both the control and L-NAME sites. Plateau defined 
as the plateau during whole body heating at a 0.8°C increase in core temperature. L-NAME sites 
were attenuated compared with control both pre- and post-BRJ. 
*, p < 0.05 vs. pre-BRJ 
#, p < 0.05 vs. control 
 
* 
* # 
# 
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Figure 7 presents the mean group L-NAME drop %CVCmax data (i.e., decrease in CVC in 
response to L-NAME infusion at the plateau of heat stress at control sites). The decrease in 
%CVCmax was significantly greater pre- to post-BRJ (pre: 39 ± 3 %CVCmax vs. post: 25 ± 4 
%CVCmax).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Values are mean ± SEM. The decrease in %CVCmax during the L-NAME infusion at 
control sites was further reduce from pre- to post-BRJ. The reduction in CVC from the plateau in 
heat stress to the plateau following L-NAME infusion in the control site (i.e., post-L-NAME 
drop) was significantly reduced from pre- to post-BRJ.  
*, p < 0.05 vs. pre-BRJ 
 
 
 
 
* 
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Figure 8 depicts mean group data of the contribution of NO to reflex cutaneous 
vasodilation. Beetroot juice augmented the NO component of reflex cutaneous vasodilation (pre-
BRJ: 44 ± 5 %CVCmax vs. post-BRJ: 64 ± 6 %CVCmax; p < 0.05). 
Figure 8. Values are group mean ± SEM. These data represent the %NOS-dependent contribution to 
vasodilation in whole body heating following three days of BRJ. There was a significant increase in 
%NOS-dependent vasodilation following three days of BRJ.  
*, p < 0.05 vs. pre-BRJ 
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Absolute maximal CVC data are shown in Table 1. Neither BRJ nor microdialysis 
treatment (control vs. L-NAME) had any effect on maximal CVC values. 
 
Absolute Maximal CVC Values 
 
Treatment Site 
 
Maximal CVC Values (mV/mmHg) 
Pre-BRJ                Control 1.72 ± 0.14 
Pre-BRJ             L-NAME 1.80 ± 0.20 
Post-BRJ               Control 1.58 ± 0.13 
Post-BRJ            L-NAME 1.74 ± 0.22 
 
Table 1. Values are group mean ± SEM. There was no significant difference in absolute 
maximal CVC between the control and L-NAME sites pre- or post-BRJ. 
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Chapter 4 - Discussion 
To our knowledge, this is the first investigation of the effects of dietary nitrate 
supplementation via beetroot juice on reflex cutaneous vasodilation in healthy humans. The 
primary finding of this investigation suggests that nitrate supplementation augments reflex 
cutaneous vasodilation significantly through both NOS-dependent and NOS-independent 
pathways, and thus may improve thermoregulation in healthy subjects. We observed a significant 
augmentation of the plateau phase of reflex cutaneous vasodilation at both the control and L-
NAME sites following three days of nitrate supplementation. The increase in CVC following 
nitrate supplementation in both treatment sites suggests a significant improvement in NO 
production through NOS-independent mechanisms (Figure 5). We also observed a greater 
decrease in CVC in response to L-NAME infusion during the plateau at the control site from pre- 
to post-BRJ. This greater reduction in the post-L-NAME drop from pre- to post-BRJ further 
suggests there is a significant improvement in the NOS-dependent component to reflex 
cutaneous vasodilation (Figure 6). These data together suggest the NO component to cutaneous 
active vasodilation may be augmented through both NOS-dependent and NOS-independent 
mechanisms. 
Despite the use of an exogenous NOS inhibitor, we observed a significant increase in 
CVC at L-NAME treatment sites during the plateau post-nitrate supplementation, which is 
suggestive of augmented NOS-independent vasodilation via exogenous bioavailable NO derived 
from beetroot juice. The conversion from nitrate to nitrite, and subsequently NO, was augmented 
in passive heat stress conditions, with increased core and arterial blood temperature and possibly 
a reduced pH (i.e., acidosis) of the blood. Nitrite reduction to NO has previously been 
demonstrated by Cosby et al. (2003) to elicit vasodilation and increase forearm blood flow in 
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humans via deoxyhemoglobin, suggesting hypoxia and acidosis are necessary to elicit reductions 
from nitrite to NO via the NOS-independent pathway (Cosby et al. 2003). Whether changes in 
skin, blood, or core temperature have a similar effect on the reduction of nitrate to nitrite to NO 
as do changes in pH and PO2 remains to be elucidated. 
 We further observed significant reductions in both diastolic and mean arterial blood 
pressure following three days of nitrate supplementation. Diastolic blood pressure and mean 
arterial blood pressure were attenuated pre- to post-nitrate supplementation at baseline and at the 
end of the protocol during thermoneutral conditions in healthy subjects. Reductions in both 
diastolic and mean arterial pressure are consistent with previous studies following nitrate 
supplementation. Webb et al. demonstrated that ingestion of nitrates (beetroot juice, 500 ml) 
lowered both systolic and diastolic blood pressures and were associated with peak concentrations 
of plasma nitrite (Webb et al. 2008). Larsen and colleagues (2006) have also observed reductions 
in diastolic and mean blood pressure in young healthy subjects after three days of sodium nitrate 
supplementation (dose of 0.1 mmol per kg of body weight). Taken together, these results are 
consistent with our findings, and further suggest that dietary nitrates were reduced to NO. 
In addition to thermoregulatory control of skin blood flow, there is also non-
thermoregulatory control of the cutaneous vasculature via the baroreflex (Kellogg et al 1990). 
Non-thermoregulatory control of skin blood flow via the baroreflex detects reductions in mean 
arterial pressure and responds by increasing sympathetic nerve activity. Cui et al. demonstrated 
increased frequency of skin sympathetic nerve activity in whole body heating, suggesting that 
activation of skin sympathetic nerve activity is centrally mediated either by vasodilator or 
sudomotor control, or both (Cui et al. 2006).  Our finding that there was no difference in mean 
arterial pressure between pre- and post-nitrate supplementation during hyperthermia suggests 
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baroreflex control of mean arterial pressure may be heightened in response to the decrease in 
resting mean arterial pressure following nitrate supplementation. During whole body heating 
post-BRJ, we observed a slight decrease in pulse pressure.  Although this decrease in pulse 
pressure was not statistically significant compared to pre-BRJ, a decrease in pulse pressure has 
been shown to elicit a pressor response (Ead et al. 1952; Sagawa 1983). It is possible that as 
pulse pressure decreases during heat stress post-BRJ a mild pressor response is elicited by the 
baroreflex maintain mean arterial pressure. It is possible in heat stress conditions that mean 
arterial pressure may be closely regulated by skin sympathetic nerve activity in the presence of 
additional bioavailable NO via nitrate supplementation. 
As previously shown, consumption of dietary nitrates elicits many potential 
cardiovascular health benefits. The findings from the present investigation are consistent with 
previous literature by demonstrating significant reductions in blood pressure in healthy 
individuals. The primary findings of the study also suggest improved microvascular function in 
young, healthy individuals due to an increase in NOS-dependent and independent vasodilation 
following nitrate supplementation. It is well known that NO is required for full expression of 
cutaneous active vasodilation, and in aging, for example, the NO component to reflex cutaneous 
vasodilation is attenuated (Holowatz et al. 2003; Kellogg et al. 1998, Shastry et al. 1998). It is 
possible that nitrate supplementation may augment NOS-dependent vasodilation in healthy, aged 
individuals, thus restoring the NO component to reflex cutaneous active vasodilation. Whether 
nitrate supplementation can augment reflex cutaneous vasodilation in healthy aging or in patient 
populations, such as hypertension or hypercholesterolemia, is unknown but our data suggest 
nitrate supplementation may be a safe and effective means by which to improve 
thermoregulation in these populations.  
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 Limitations 
There are at least two limitations to address in the present investigation. The first 
experimental limitation was the use of L-NAME as a non-selective NOS isoform inhibitor. 
Specific eNOS and nNOS isoform inhibitors would have allowed for quantification of each 
respective NOS isoform contribution to the response. By use of specific NOS isoform inhibitors 
we would have been able to determine any differences from pre- to post-BRJ and if one specific 
NOS isoform was upregulated versus another after consumption of beetroot juice. Second, we 
did not quantify serum levels of plasma nitrate and nitrite from pre- to post-BRJ. Measuring 
changes in plasma nitrate and nitrite levels would have allowed us to determine if changes in 
blood pressure were correlated to peak nitrite levels pre- to post-supplement intervention as 
previously discussed and presented in current mechanistic studies with nitrate supplementation 
(Webb et al. 2008). Although indirect, our data, demonstrating a reduction in both diastolic and 
mean arterial blood pressure, would appear to confirm that three days of nitrate supplementation 
was adequate in increasing plasma nitrate and nitrite concentrations.  
 Conclusions 
To our knowledge, this is the first study to identify a role for dietary nitrate 
supplementation via beetroot juice on the skin blood flow response to reflex cutaneous 
vasodilation. Our data suggest dietary nitrate supplementation augmented reflex cutaneous 
vasodilation in young, healthy subjects via: 1) NOS-independent vasodilation, as evidenced by 
an increase in CVC from pre-to post-BRJ in the plateau phase for both control and L-NAME 
treatment sites; and 2) NOS-dependent vasodilation, as evidenced by a larger reduction in CVC 
during the post-L-NAME drop phase of the whole body heating protocol. These data suggest that 
dietary nitrate supplementation via beetroot juice is a safe and effective method for improving 
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thermoregulation in young, healthy humans, as evidenced by increasing reflex cutaneous 
vasodilation via both NOS-dependent and NOS-independent pathways. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
23 
 
References 
Bailey SJ, Winyard P, Vanhatalo A, Blackwell JR, DiMenna FJ, Wilkerson DP, Tarr J, Benjamin 
N, Jones AM (2009). Dietary nitrate supplementation reduces the O2 cost of low-intensity 
exercise and enhances tolerance to high-intensity exercise in humans. J Appl Physiol 107: 
1144-1155. 
Benjamin N, O’Driscoll F, Duncan C, Smith L, Golden M (1994). Stomach NO synthesis. 
Nature 368: 502. 
Bennett LAT, Johnson JM, Stephens DP, Saad AR, Kellogg DL Jr (2003). Evidence for a role 
for vasoactive intestinal peptide in active vasodilatation in the cutaneous vasculature of 
humans. J Physiol 552: 223-232. 
Cosby K, Partovi KS, Crawford JH, Patel RP, Reiter CD, Martyr S, Yang BK, Waclawiw MA, 
Zalos G, Xu X, Huang KT, Shields H, Kim-Shapiro DB, Schechter AN, O Cannon III R, 
Gladwin MT (2003). Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the 
human circulation. Nature Medicine 9: 1498-1505. 
Cui J, Sathishkumar M, Wilson TE, Shibasaki M, Davis SL, Crandall CG (2006). Spectral 
characteristics of skin sympathetic nerve activity in heat-stressed humans. Am J Physiol 
Heart Circ Physiol 290: H1601-H1609. 
Ead HW, Green JH, Neil E (1952).  A comparison of the effects of pulsatile and non-pulsatile 
blood flow through the carotid sinus on the reflexogenic activity of the sinus baroreceptors 
in the cat.  J Physiol 118: 509-519. 
Edholm OG, Fox RH, MacPherson RK (1957). Vasomotor control of the cutaneous blood 
vessels in the human forearm. J Physiol 139: 455-465. 
Ferguson SK, Hirai DM, Copp SW, Holdsworth CT, Allen JD, Jones AM, Musch TI, Poole DC 
(2013). Impact of dietary nitrate supplementation via beetroot juice on exercising muscle 
vascular control in rats. J Physiol 591: 547-557. 
Fox RH, Hilton SM (1958). Bradykinin formation in human skin as a factor in heat 
vasodilatation. J Physiol 142: 219-232. 
Govoni M, Jansson EA, Weitzberg E, Lundberg JO (2008). The increase in plasma nitrite after a 
dietary nitrate load is markedly attenuated by an antibacterial mouthwash. Nitric Oxide 19: 
333-337. 
Hodges GJ, Chiu C, Kosiba WA, Zhao K, Johnson JM (2009). The effect of microdialysis needle 
trauma on cutaneous vascular responses in humans. J Appl Physiol 106: 1112-1118. 
Holowatz LA, Houghton BL, Wong BJ, Wilkins BW, Harding AW, Kenney WL, Minson CT 
(2003). Nitric oxide and attenuated reflex cutaneous vasodilation in aged skin. Am J 
Physiol Heart Circ Physiol 284: H1662-H1667. 
24 
 
Holowatz LA, Thompson-Torgerson CS, Kenney WL (2008). The human cutaneous circulation 
as a model of generalized microvascular function. J Appl Physiol 105: 370-372. 
Johnson JM, Kellogg DL Jr (2010). Thermoregulatory and thermal control in the human 
cutaneous circulation. Front Biosci (Schol Ed) 2: 825-853 
Kellogg DL Jr (2006). In vivo mechanisms of cutaneous vasodilation and vasoconstriction in 
humans during thermoregulatory challenges. J Appl Physiol 100: 1709-1718. 
Kellogg DL Jr, Crandall CG, Liu Y, Charkoudian N, Johnson JM (1998). Nitric oxide and 
cutaneous active vasodilation during heat stress in humans. J Appl Physiol 85: 824-829. 
Kellogg DL Jr, Johnson JM, Kosiba WA (1990). Baroreflex control of the cutaneous active 
vasodilator system in humans. Circ Res 66: 1420-1426. 
Kellogg DL Jr, Liu Y, Kosiba IF, O'Donnell D (1999). Role of nitric oxide in the vascular effects 
of local warming of the skin in humans. J Appl Physiol 86: 1185-1190. 
Kellogg DL Jr, Pergola PE, Piest KL, Kosiba WA, Crandall CG, Grossmann M, Johnson JM 
(1995). Cutaneous active vasodilation in humans is mediated by cholinergic nerve 
cotransmission. Circulation Research 77: 1222-1228. 
Kellogg DL Jr, Zhao JL, Wu Y (2008). Neuronal nitric oxide synthase control mechanisms in the 
cutaneous vasculature of humans in vivo. J Physiol 586: 847-857. 
Kellogg DL Jr, Zhao JL, Wu Y, Johnson JM (2010). VIP/PACAP receptor mediation of 
cutaneous active vasodilation during heat stress in humans. J Appl Physiol 109:95-100. 
Kenjale AA, Ham KL, Stabler T, Robbins JL, Johnson JL, VanBruggen M, Privette G, Yim E, 
Kraus WE, Allen JD (2011). Dietary nitrate supplementation enhances exercise 
performance in peripheral arterial disease. J Appl Physiol 110: 1582-1591. 
Larsen FJ, Weitzberg E, Lundberg JO, Ekblom B (2007). Effects of dietary nitrate on oxygen 
cost during exercise. Acta Physiol 191: 59-66. 
Larsen FJ, Ekblom B, Sahlin K, Lundberg JO, Weitzberg E (2006). Effects of dietary nitrate on 
blood pressure in healthy volunteers. N Engl J Med 355: 2792-2793. 
Lundberg JO, Weitzberg E, Alving K (1994). Intragastric nitric oxide production in humans: 
Measurements in expelled air. Gut 35: 1543-1546. 
Lundberg JO, Govoni M (2004). Inorganic nitrate is a possible source for systemic generation of 
nitric oxide. Free Radic Biol Med 37: 395-400. 
Lundberg JO, Weitzberg E, Gladwin MT (2008). The nitrate-nitrite-nitric oxide pathway in 
physiology and therapeutics. Nat Rev Drug Discov 7: 156-167. 
McCord GR, Cracowski J, Minson CT (2006). Prostanoids contribute to cutaneous active 
25 
 
vasodilation in humans. Am J Physiol Regul Integr Comp Physiol 291: R596-R602. 
Moncada S, Higgs A (1993). The L-arginine-nitric oxide pathway. N Engl J Med 329: 2002-
2012. 
Rowell LB (1974). Human cardiovascular adjustments to exercise and thermal stress. Physiol 
Rev 54: 75-159. 
Sagawa K (1983).  Baroreflex control of systemic arterial pressure and vascular bed.  In 
Handbook of Physiology, Chapter 14, pages 453-496. 
Shastry S, Dietz NM, Halliwill JR, Reed AS, Joyner MJ (1998). Effects of nitric oxide synthase 
inhibition on cutaneous vasodilation during body heating in humans. J Appl Physiol 85: 
830-834. 
Vanhatalo A, Bailey SJ, Blackwell JR, DiMenna FJ, Pavey, TG, Wilkerson DP, Benjamin N, 
Winyard PG, Jones AM (2010). Acute and chronic effects of dietary nitrate 
supplementation on blood pressure and the physiological responses to moderate-intensity 
and incremental exercise. Am J Physiol Regul Integr Comp Physiol 299: R1121-R1131. 
Webb AJ, Patel N, Loukogeorgakis S, Okorie M, Aboud Z, Misra S, Rashid R, Miall P, 
Deanfield J, Benjamin N, MacAllister R, Hobbs AJ, Ahluwalia A (2008). Acute blood 
pressure lowering, vasoprotective, and antiplatelet properties of dietary nitrate via 
bioconversion to nitrite. Hypertension 51: 784-790. 
Wilkins BW, Holowatz LA, Wong BJ, Minson CT (2003). Nitric oxide is not permissive for 
cutaneous active vasodilatation in humans. J Physiol 548: 963-969. 
Wong BJ, Fieger SM (2012). Transient receptor potential vanilloid type 1 channels contribute to 
reflex cutaneous vasodilation in humans. J Appl Physiol 112: 2037-2042. 
Wong BJ, Tublitz NJ, Minson CT (2005). Neurokinin-1 receptor desensitization to consecutive 
microdialysis infusions of substance P in human skin. J Physiol 568: 1047-1056. 
Wong BJ, Wilkins BW, Minson CT (2004). H1 but not H2 histamine receptor activation 
contributes to the rise in skin blood flow during whole body heating in humans. J Physiol 
560: 941-948. 
 
 
 
 
 
 
 
26 
 
Appendix A - Individual Responses  
 
 
 
 
Figure A.1. These data represent the individual responses of all subjects (n = 7) of the NO-
component to reflex cutaneous vasodilation from pre- to post-BRJ. Group mean data (solid line) 
represents the increase in %NO-dependent vasodilation in all subjects from pre- to post-BRJ.  
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Appendix B – Control Site Skin Blood Flow Tracing  
 
 
 
 
Figure B.2. A representative tracing of the skin blood flow response to reflex cutaneous 
vasodilation in one subject in the control site from pre-BRJ (gray line) to post-BRJ (black line). 
This figure suggests improved NOS-dependent and NOS-independent vasodilation. Improved 
NOS-dependent vasodilation was demonstrated by a further reduction in CVC during the post-L-
NAME drop, post-BRJ. Improved NOS-independent vasodilation was suggested by an increase 
in CVC in the whole body heating plateau of the protocol post-BRJ.  
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Appendix C – L-NAME Site Skin Blood Flow Tracing 
 
 
 
 
Figure C. 3. A representative tracing of the skin blood flow response to reflex cutaneous 
vasodilation in one subject in the L-NAME treatment site from pre-BRJ (gray line) to post-BRJ 
(black line). This figure suggests an improved NOS-independent vasodilation as demonstrated by 
an increase in CVC in the plateau phase of whole body heating post-BRJ. This increase in CVC 
in a NOS-inhibited treatment site suggests an increase in NOS-independent vasodilation post-
BRJ. 
 
	  
